)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Jazz Pharmaceuticals (JAZZ) investor relations material
Jazz Pharmaceuticals Corporate Presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate Presentation summary12 Dec, 2025
Strategic vision and corporate overview
Focused on developing innovative, life-changing medicines for serious diseases with limited treatment options.
Mission to transform the lives of patients and their families through novel therapies.
Strong emphasis on operational excellence and disciplined capital allocation to drive shareholder value.
Commercial execution and product portfolio
Diverse portfolio spans neuroscience (sleep, epilepsy) and oncology, with leading products like Xywav, Epidiolex, Zepzelca, Rylaze, and Modeyso.
Xywav is the #1 branded treatment for narcolepsy and the only approved therapy for idiopathic hypersomnia, with $431M in 3Q25 revenue (11% YoY growth).
Epidiolex is the #1 branded epilepsy treatment, poised to reach blockbuster status in 2025, with $303M in 3Q25 revenue (20% YoY growth).
Zepzelca approved for 1L ES-SCLC maintenance, included in NCCN Guidelines, and showing improved survival in clinical trials.
Rylaze is the standard of care for pediatric ALL/LBL patients with hypersensitivity to E. coli-derived asparaginase.
Modeyso launched as the first and only FDA-approved treatment for recurrent H3 K27M-mutant diffuse midline glioma.
Pipeline and R&D investments
Robust pipeline with key programs: zanidatamab (HER2+ cancers), dordaviprone (glioma), JZP815 (pan-RAF inhibitor), and JZP898 (conditionally-activated IFNa therapy).
Zanidatamab demonstrated positive Phase 3 results in GEA, ongoing launches in BTC, and broad potential in multiple HER2+ tumors.
Dordaviprone in confirmatory Phase 3 ACTION study for H3 K27M-mutant diffuse glioma, with interim OS analysis expected late 2026/early 2027.
JZP815 and JZP898 in Phase 1 trials targeting solid tumors with MAPK pathway alterations and advanced solid tumors, respectively.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Jazz Pharmaceuticals earnings date
Status Update9 Jan, 2026
Next Jazz Pharmaceuticals earnings date
Status Update9 Jan, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Jazz Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing treatments for neurological disorders, sleep medicine, and oncology. The company’s portfolio includes products designed to address rare and complex conditions, particularly in the areas of sleep disorders, epilepsy, and cancer. Jazz Pharmaceuticals engages in research, development, and global distribution of its therapies, working to advance treatment options for patients with unmet medical needs. The company is headquartered in Dublin, Ireland, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage